Mirror Now
@mirrornow·2.2M subscribers·145K videos
Russia Develops Groundbreaking mRNA Cancer Vaccine Worth Rs 2.47 Crore; To Distribute For Free
Posted
December 19, 2024
Views
4,390
Likes
60
Comments
8
Engagement
December 19, 2024
4,390
60
8
1.55%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
You’re on December 19, 2024. Earlier episodes are to the left, later ones to the right — the row keeps loading as you go. Click any card to open it.
Dec 19, 20243:01Now PlayingRussia has developed a personalised mRNA cancer vaccine, launching in 2025, using patient tumor material. Distributed free, it costs 300,000 rubles per dose. The vaccine trains immunity to target cancer cells. With 635,000 cancer cases reported in 2022, it mirrors US and UK efforts in personalised treatment trials.
.
.
.
#cancertreatment #mrnavaccine #personalisedmedicine #cancerresearch #medicalbreakthrough #russiahealth #cancerimmunotherapy #tumorvaccine #oncologyadvancements #globalhealth #cancercare #medicaltechnology #mirrornow #mirrornoworiginalsSUBSCRIBE NOW |
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Subscribe to our other network channels:
Times Now Navbharat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
